Recommended Practices for Cleaning, Handling, and Processing Anesthesia Equipment
2005; Wiley; Volume: 81; Issue: 4 Linguagem: Inglês
10.1016/s0001-2092(06)60365-7
ISSN1878-0369
Tópico(s)Safe Handling of Antineoplastic Drugs
ResumoAORN JournalVolume 81, Issue 4 p. 856-870 Other Recommended Practices for Cleaning, Handling, and Processing Anesthesia Equipment Correction(s) for this article CORRECTIONS Volume 82Issue 1AORN Journal pages: 16-16 First Published online: July 1, 2005 First published: 01 April 2005 https://doi.org/10.1016/S0001-2092(06)60365-7Citations: 13 Originally published June 1977, AORN Journal, as AORN's Recommended practices for cleaning and processing anesthesia equipment.” Revised March 1978; July 1982; March 1991. Published as proposed recommended practices September 1994. Revised; published November 1999, AORN Journal. Reformatted July 2000. Revised November 2004; scheduled for publication in the AORN Journal in 2005. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Notes 1WA Rutala, APIC Guidelines Committee. “APIC guideline for selection and use of disinfectants”. American Journal of Infection Control. August 1996; 24: 313–342. 2Centers for Disease Control and Prevention. “Postsurgical infections associated with an extrinsically contaminated intravenous anesthetic agent— California, Illinois, Maine, and Michigan, 1990”. Morbidity and Mortality Weekly Report. June 29, 1990; 39: 426–427, 433. 3MJ Daily, JB Dickey, KH Packo. “Endogenous Candida endophthalmitis after intravenous anesthesia with propofol”. Archives of Ophthalmology. August 1991; 109: 1081–1084. 4M E Villarino et al, “Postsurgical infectious associated with an extrinsically contaminated intravenous anesthetic agent,” program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, 29 Sept-2 Oct 1991. 5B Veber, et al. “Severe sepsis after intravenous injection of contaminated Propofol”. Anesthesiology. March 1994; 80: 712–713. 6K Kidd-Ljunggren, et al. “Nosocomial transmission of hepatitis B virus infection through multipledose vials”. Journal of Hospital Infection. September 1999; 43: 57–62. 7MJ Kuehnert, et al. “Staphylococcus aureus bloodstream infections among patients undergoing electroconvulsive therapy traced to breaks in infection control and possible extrinsic contamination by Propofol”. Anesthesia and Analgesia. August 1997; 85: 420–425. 8M Massari, et al. “Transmission of hepatitis C virus in a gynecological surgery setting”. Journal of Clinical Microbiology. August 2001; 39: 2860–2863. 9Centers for Disease Control and Prevention. “Transmission of hepatitis B and C viruses in outpatient settings—New York, Oklahoma, and Nebraska, 2000–2002”. Morbidity and Mortality Weekly Report. Sept 26, 2003; 52: 901–906. 10JM Boyce, D Pittet. “Guideline for hand hygiene in health-care settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/ISAD Hand Hygiene Taskforce”. Morbidity and Mortality Weekly Report. Oct 25, 2002; 51(RR16): 1–44. 11CE Blogg, MA Ramsey, JD Jarvis. “Infection hazard from syringes”. British Journal of Anaesthesia. April 1974; 46: 260–262. 12MR Lessard, et al. “A microbiological study of the contamination of the syringes used in anaesthesia practice”. Canadian Journal of Anaesthesia. November 1988; 35: 567–569. 13CT Lutz, et al. “Allergy testing of multiple patients should no longer be performed with a common syringe”. The New England Journal of Medicine. May 17, 1984; 310: 1335–1337. 14JW Koepke, JC Selner. “Allergy testing of multiple patients with a common syringe”. The New England Journal Medicine. Nov 1, 1984; 311: 1188–1189. 15DJ Shulan, et al. “Contamination of intradermal skin test syringes”. Journal of Allergy and Clinical Immunology. August 1985; 76: 226–227. 16JW Koepke, et al. “Viral contamination of intradermal skin test syringes”. Annals of Allergy. December 1985; 55: 776–778. 17A Carbonne et al, “Patient to patient transmission of hepatitis C in surgery clinic through multidose vials,” abstract presented at the 13th annual meeting of the Society for Healthcare Epidemiology of America, Arlington Va, 5–8 April 2003. 18A Fleming, AC Ogilvie. “Syringe needles and mass inoculation technique”. British Medical Journal. March 17, 1951; 1: 543–546. 19RR Hughes. “Post-penicillin jaundice”. British Medical Journal. Nov 9, 1946; 2: 685–688. 20R Uren, C Commens, R Howman-Giles, “Intradermal injections: A potential health hazard?”Medical Journal of Australia 161 (August 994) 226. 21HA Hein, et al. “Recapping needles in anesthesia—Is it safe?”. Anesthesiology. September 1987; 67: A161. 22CA Trepanier, et al. “Risk of cross-infection related to the multiple use of disposable syringes”. Canadian Journal of Anaesthesia. March 1990; 37: 156–159. 23JL Parlow. “Blood contamination of drug syringes used in anaesthesia”. Canadian Journal of Anaesthesia. 1989; (36 suppl): S61–S62. 24B Meier. “Reuse of needle at hospital infects 50 with hepatitis C”. New York Times. Oct 10, 2002. 25Association for the Advancement of Medical Instrumentation. “Safe handling and biological decontamination of reusable medical devices in health care facilities and in nonclinical settings; ANSI/AAMI ST35”. Arlington, Va: Association of the Adcancement of Medical Instrumentation. 2003, 16. 26 “Sterilization or disinfection of medical devices: General principles,” Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/hip/sterile/sterilgp.htm (accessed 24 Sept 2004). 27 “Recommended practices for high-level disinfection”. In Standards, Recommended Practices, and Guidelines. Denver: AORN, Inc. 2004, 235–240. 28 “Recommended practices for sterilization in the practice setting”. In Standards, Recommended Practices, and Guidelines. Denver: AORN, Inc. 2004, 373–384. 29American Society of Anesthesiologists Committee on Occupational Health of Operating Room Personnel. Recommendations for Infection Control for the Practice of Anesthesiology. second ed. Park Ridge, III: American Society of Anesthesiologists. 1998, Also available at http://www.asahq.org/publicationsAndServices/infectioncontrol.pdf (accessed 24 May 2004). 30American Association of Nurse Anesthetists. Infection Control Guide. Park Ridge, III: American Association of Nurse Anesthetists. 1997, 13–23. 31JE Foweraker. “The laryngoscope as a potential source of cross-infection”. Journal of Hospital Infections. April 1995; 29: 315–316. 32TJ Neal, et al. “The neonatal laryngoscope as a potential source of cross-infection”. Journal of Hospital Infections. August 1995; 30: 315–317. 33KE Nelson, et al. “Transmission of neonatal listerosis in a delivery room”. American Journal of Diseases of Children. September 1985; 139: 903–905. 34 “Recommended practices for cleaning and processing endoscopes and endoscope accessories”. In Standards, Recommended Practices, and Guidelines. Denver: AORN, Inc. 2004, 261–266. 35Centers for Disease Control and Prevention. “Bronchoscopy-related infections and pseudoinfections—New York, 1996 and 1998”. Morbidity and Mortality Weekly Report. July 9, 1999; 48: 557–560. 36US Department of Health and Human Services. “Infections from inadequately processed endoscopes”. User Facility Reporting. Fall 1999; 28: 1–5. 37“Manufacturer and User Facility Device Experience Database. Report Numbers 2084725–2002–00033; 2084725–2003–00084; 2084725–2004–00010; 2084725–2004–00003; 2084725–2004–00011; 2084725–2004–00012; 3003723454–2004–0001,” US Food and Drug Administration, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/Search.cfm (accessed 30 Sept 2004). 38 “Manufacturer and User Facility Device Experience Database. Report Numbers 2084725–2003–00008; 3003723454–2004–0001,” US Food and Drug Administration. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/Search.cfm (accessed 30 Sept 2004). 39HJ O'Conner, JR Babb, GA Ayliffe. “Pseudomonas aeruginosa infection in endoscopy”. Gastroenterology. December 1987; 93: 1451. 40JI Allen, et al. “Pseudomonas infection of the biliary system resulting from use of contaminated endoscope”. Gastroenterology. March 1987; 92: 759–763. 41DE Low, et al. “Infectious complications of endoscopic retrograde cholangio-pancreatography. A prospective assessment”. Archives of Internal Medicine. August 1980; 140: 1076–1077. 42MJ Arfa, DL Sitter. “In-hospital evaluation of contamination of duodenoscopes: A quantitative assessment of the effect of drying”. Journal of Hospital Infections. October 1991; 19: 89–98. 43CJ Alvarado, M Reichelderfer. “APIC guideline for infection prevention and control in flexible endoscopy”. American Journal of Infection Control. April 2000; 18: 138–155. 44RC Morell, et al. “A survey of laryngoscope contamination at a university and a community hospital”. Anesthesiology. April 1994; 80: 960. 45RA Phillips, WP Monaghan. “Incidence of visible and occult blood on laryngoscope blades and handles”. AANA Journal. June 1997; 65: 241–246. 46Centers for Disease Control and Prevention. “Guidelines for environmental infection control in health-care facilities: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC)”. Morbidity and Mortality Weekly Report. June 6, 2003; 52(No RR-10): 22. 47JR Hall. “Blood contamination of anesthesia equipment and monitoring equipment”. Anesthesia and Analgesia. June 1994; 78: 1136–1139. 48SM Perry, WP Monghan. “The prevalence of visible and/or occult blood on anesthesia and monitoring equipment”. Journal of the American Association of Nurse Anesthetists. February 2001; 69: 44–48. 49H Arkoff, RA Ortega. “Touchscreen technology: Potential source of cross-infections”. Anesthesia and Analgesia. December 1992; 75: 1073. 50MS Kristensen, E Sloth, TK Jensen. “Relationship between anesthetic procedure and contact of anesthesia personnel with patient body fluids”. Anesthesiology. October 1990; 73: 619–624. 51LA Herwaldt, JM Pottinger, SA Coffin. “Nosocomial infections associated with anesthesia”. In CG Mayhall, ed. Hospital Epidemiology and Infection Control. third ed. Philadelphia: Lippincott Williams & Wilkins. 2004. 52US Food and Drug Administration. “Important enforcement date for reprocessing single-use devices,”User facility Reporting 39 (Summer 2002) Also available at http://www.fda.gov/cdrh/fusenews/ufb/39.html#1 (accessed 24 Sept 2004). 53 “Anesthesia apparatus checkout recommendations, 1993,” US Food and Drug Administration. http://www.fda.gov/cdrhf/humfac/anesckot.html (accessed 24 Sept 2004). 54 “Guidelines for determining anesthesia machine obsolescence,” American Society of Anesthesiologists. http://wmw.asahq.org/PublicationsAndServices/machineobsolescense.pdf (accessed 24 Sept 2004). 55B Abraham, et al. “Malignant hyperthermia susceptibility: Anaesthetic implications and risk stratification”. Quarterly Journal of Mediane. January 1997; 90: 13–18. 56 “Medical FAQs,” Malignant Hyperthermia Association of the United States. http://www.mhaus.org/index.cfm/fuseaction/Content.Display/PagePK/MedicalFAQs.cfm (accessed 24 Sept 2004). 57 “Reducing mercury use in healthcare: Promoting a healthier environment: A how-to manual,” US Environmental Protection Agency. http://www.epa.gov/glnpo/bnsdocs/merchealth/ (accessed 24 Sept 2004). 58Centers for Disease Control and Prevention. “Guidelines for prevention of nosocomial pneumonia, 2003”. Morbidity and Mortality Weekly Report. March 26, 2004; 53(RR03): 1–36. 59GE Dryden. “Risk of contamination from the anesthesia circle absorber: An evaluation”. Anesthesia and Analgesia. November/December 1969; 48: 939–943. 60JR Jenkins, WM Edgar. “Sterilization of anaesthetic equipment”. Anaesthesia. April 1964; 19: 177–190. 61PM Murphy, RB Fitzgeorge, F Barrett. “Viability and distribution of bacteria after passage through a circle anaesthetic system”. British Journal of Anaesthesia. March 1991; 66: 300–304. 62DT Leijten, VS Rejger, RP Mouton. “Bacterial contamination and the effect of filters in anaesthetic circuits in a simulated patient model”. Journal of Hospital Infections. May 1992; 21: 51–60. 63GE Dryden. “Uncleaned anesthesia equipment”. JAMA. September 1975; 233: 1297–1298. 64BC Stratford, RR Clark, S Dixson. “The disinfection of anaesthetic apparatus”. British Journal of Anaesthesia. August 1964; 36: 471–476. 65 “Bacterial contamination of anesthesia machines revealed”. In Excerpta Medica. Lawrenceville, NJ: Convention Reporter. 1991, 12–14. 66H Aranha-Creado, et al. “Removal of Mycobacterium species by breathing circuit filters”. Infection Control and Hospital Epidemiology. April 1997; 18: 252–254. 67AJ Berry, FS Nolte. “An alternative strategy for infection control of anesthesia breathing circuits: A laboratory assessment of the Pall HME filter”. Anesthesia and Analgesia. May 1991; 72: 651–655. 68I Hogbarth. “Anaesthetic machine and breathing system contamination and the efficacy of bacterial/viral filters”. Anaesthesia and Intensive Care. April 1996; 25: 154–163. 69G Lloyd, et al. “Barriers to hepatitis C transmission within breathing systems: Efficacy of a pleated hydrophobic filter”. Anaesthesia and Intensive Care. June 1997; 25: 235–238. 70HH Luttropp, L Berntman. “Bacterial filters protect anaesthetic equipment in a low-flow system”. Anaesthesia. June 1993; 48: 520–523. 71J Rathgeber, et al. “Prevention of patient bacterial contamination of anaesthesia-circle-systems: A clinical study of the contamination risk and performance of different heat and moisture exchanges with electret filter (HMEF)”. European Journal of Anaesthesia. July 1997; 14: 368–373. 72GM Shiotani, et al. “Prevention of contamination of the circle system and ventilators with a new disposable filter”. Anesthesia and Analgesia. September/October 1971; 50: 844–845. 73C Smith, et al. “An evaluation of one and two airflow filters preventing the movement of bacterial through the anesthesia circle system”. Journal of the American Association of Nurse Anesthetists. April 1996; 64: 153–156. 74S Van Hassel, et al. “Bacterial filters in anesthesia: Results of nine years of surveillance”. Infection Control and Hospital Epidemiology. January 1999; 20: 58–60. 75K Chant, et al. “Investigation of possible patient-to-patient transmission of hepatitis C in a hospital”. New South Wales Public Health Bulletin. May 1994; 5: 47–51. 76Association of Anaesthetists of Great Britain and Ireland. Infection Control in Anaesthesia. London: The Association of Anaesthetists of Great Britain and Ireland. 2002, 4. 77 “Policy on infection control in anaesthesia, 1995,” Australian and New Zealand College of Anaesthetists. http://www.medeserv.com.au/anzca/pdfdocs/P28_1995.PDF (accessed 25 Sept 2004). 78 “Anesthetic management of a SARS-Infected patient,” Canadian Society of Anesthesiologists. http://www.asahq.org/clinical/pracadvsars.htm (accessed 25 Sept 2004). 79Centers for Disease Control and Prevention. “Guidelines for prevention of nosocomial pneumonia”. Morbidity and Mortality Weekly Report. Jan 3, 1997; 46(RR-1): 1–77. 80PM Anrow, et al. “Nosocomial Legionnaire's disease caused by aerosolized tap water from respiratory devices”. Journal of Infectious Diseases. October 1982; 146: 460–467. 81DE Craven, TA Goularte, BJ Make. “Contaminated condensate in mechanical ventilator circuits: A risk factor for nosocomial pneumonia?”. American Review of Respiratory Disease. April 1984; 129: 625–628. 82 “Bloodborne pathogens—1910.1030,” US Department of Labor, Occupational Safety, and Health Administration. http://www.oshaslc.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=10051 (accessed 25 Sept 2004). 83 “RCA online,” US Environmental Protection Agency. http://www.epa.gov/rcraonline/ (accessed 25 Sept 2004). 84 “Identification and listing of hazardous waste,” in Electronic Code of Federal Regulations (e-CFR) 40: Protection of Environment, Part 261. http://www.epa.gov/epahome/cfr40.htm (accessed 25 Sept 2004). 85 “Recommended practices for standard and transmission-based precautions,” in. In Standards, Recommended Practices, and Guidelines. Denver: AORN, Inc. 2004, 361–366. 86 “Hazard communication in the 21st century workplace,” US Department of Labor, Occupational Safety and Health Administration. http://www.osha.gov/dsg/hazcom/finalmsdsreport.html (accessed 25 Sept 2004). 87 “Bloodborne pathogens and needlestick prevention,” Occupational Safety and Health Administration. http://www.osha.gov/SLTC/blood-bornepathogens/index.html (accessed 25 Sept 2004). 88Joint Commission on Accreditation of Healthcare Organizations. “Crosswalk of 2003 standards for hospitals to 2004 leadership standards for hospitals”. In 2004 Comprehensive Accreditation Manual for Hospitals: The Official Handbook. Oakbrook Terrace, III: Joint Commission on Accreditation of Healthcare Organizations. 2003, LD.3.20. Citing Literature Volume81, Issue4April 2005Pages 856-870 ReferencesRelatedInformation
Referência(s)